Zydus Lifesciences Ltd has received final approval from the USFDA to market its generic Sacubitril and Valsartan tablets for treating chronic heart failure in adults. The tablets come in strengths of 24 mg/26 mg, 49 mg/51 mg, and 97 mg/103 mg. The drug will be manufactured in Ahmedabad.
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.